A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

1972 • 31,801 citations

Enzymatic Determination of Total Serum Cholesterol

1974 • 9,182 citations

Quantitative Determination of Serum Triglycerides by the Use of Enzymes

1973 • 3,206 citations

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

1990 • 2,936 citations

Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions

1970 • 2,523 citations

Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA

1973 • 1,457 citations

Identification of multiple subclasses of plasma low density lipoproteins in normal humans.

1982 • 995 citations

Familial lipoprotein disorders in patients with premature coronary artery disease.

1992 • 607 citations

Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B

1993 • 556 citations

Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.

1993 • 356 citations

Familial Combined Hyperlipidemia Workshop

1989 • 215 citations

Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety

1995 • 161 citations

Insulin resistance and lipoprotein metabolism

1995 • 136 citations

The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism

1993 • 116 citations

Genetic Basis of Lipoprotein Disorders

1995 • 111 citations

Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: Evidence for reduced assembly and secretion of triglyceride-rich lipoproteins

1992 • 91 citations

Comparative Efficacy and Safety of Micronized Fenofibrate and Simvastatin in Patients With Primary Type Ha or IIb Hyperlipidemia

1994 • 89 citations

A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non—Insulin-dependent diabetes mellitus and hyperlipoproteinemia

1995 • 87 citations

Effect of apolipoprotein E polymorphism and Xbal polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non‐familial hypercholesterolaemia

1991 • 73 citations

Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion

1993 • 69 citations

Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern.

1994 • 65 citations

Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia

1993 • 58 citations

Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapy

1994 • 49 citations

Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome

1993 • 40 citations

Influence of lovastatin on concentrations and composition of lipoprotein subfractions

1990 • 23 citations

Postprandial changes in apolipoprotein(a) concentration of triglyceride-rich lipoproteins can be reproduced by in vitro incubation: implications for underlying mechanism

1993 • 6 citations